Talk:Oroboros contact: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:BB-Bioblast.jpg|left|40px|link=http://www.bioblast.at/index.php/Bioblast:About|Bioblast wiki]] | [[Image:BB-Bioblast.jpg|left|40px|link=http://www.bioblast.at/index.php/Bioblast:About|Bioblast wiki]] | ||
== Popular Bioblast page == | == Popular Bioblast page == | ||
::: [[OROBOROS | ::: [[OROBOROS Contact]] has been accessed more than | ||
::::* 35,000 times (2017-02-17) | ::::* 35,000 times (2017-02-17) | ||
::::* 30,000 times (2016-10-19) | ::::* 30,000 times (2016-10-19) |
Revision as of 10:29, 6 March 2017
Popular Bioblast page
- OROBOROS Contact has been accessed more than
- 35,000 times (2017-02-17)
- 30,000 times (2016-10-19)
- 25,000 times (2016-06-21)
- 20,000 times (2016-03-13)
- 15,000 times (2015-12-22)
- 5,000 times (2015-05-03)
- OROBOROS Contact has been accessed more than
- This page was started on 2014-05-14
Completed research projects and previous collaborations
- MitoCom Tyrol
- The Oncotyrol research project has its focus on functional differences of mitochondria in human prostate tumor versus benign tissue, and comparison of primary tissue with cultured cells. - Oncotyrol
- Oncotyrol PhaseOut: MitoOnco
- Pharmacology: mitochondrial function in brain tissues
- Johannes Burtscher, PhD., MSc.
- FWF projects W1206-B05 and I-977-B24.
- Project leader: A.Univ. Prof. Dr. Christian Schwarzer, Dept. Pharmacology, Medical University Innsbruck, Austria
Previous team members
David Harrison
- David K Harrison, Doc., PhD. - [email protected]
- David has retured as of August 2016 as an independent Senior Scientific Expert in collaboration with OROBOROS INSTRUMENTS. David remains in contact with the OROBOROS-Team to support our projects with his invaluable experience in spectrophotometry.
- NextGen-O2k, development of O2k-Spectrophotometry
- Previous address: Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
OROBOROS-team
Sled adventure: The OROBOROS-Team on 2016-02-13